NR 565 Final Exam: Advanced Pharmacology
Fundamentals V3 Updated and Latest Questions and
Correct Answers with Rationale
1. Which pharmacokinetic process is most affected by the first-pass effect?
A. Metabolism
B. Excretion
C. Absorption
D. Distribution
Ans: A
Rationale: The first-pass effect primarily involves the metabolism of a drug within the liver. When an
oral medication is absorbed from the gastrointestinal tract, it enters the portal circulation. This process
allows the liver to chemically alter the drug before it reaches the systemic bloodstream. Consequently,
the bioavailability of the drug can be significantly reduced depending on the liver’s efficiency. Prescribers
must consider this when transitioning from intravenous to oral dosing routes. Understanding this
mechanism helps in predicting potential therapeutic failures or toxicities.
2. Which enzyme system is primarily responsible for the phase I metabolism of most drugs?
A. Alcohol dehydrogenase
B. Glucuronosyltransferase
C. Monoamine oxidase
D. Cytochrome P450
Ans: D
,Rationale: The Cytochrome P450 enzyme system is the major catalyst for drug biotransformation in
humans. These enzymes are located mainly in the endoplasmic reticulum of hepatocytes. They facilitate
oxidation, reduction, and hydrolysis reactions during phase I metabolism. Variability in these enzymes
can lead to significant differences in drug response among patients. Some drugs may induce or inhibit
these enzymes, leading to complex drug-drug interactions. Proper assessment of a patient’s medication
profile requires knowledge of these metabolic pathways.
3. What is the primary mechanism of action of ACE inhibitors in treating hypertension?
A. Inhibiting the conversion of Angiotensin I to Angiotensin II
B. Blocking calcium entry into smooth muscle
C. Antagonizing beta-1 adrenergic receptors
D. Promoting sodium excretion in the distal tubule
Ans: A
Rationale: ACE inhibitors work by blocking the enzyme responsible for creating Angiotensin II.
Angiotensin II is a potent vasoconstrictor that also stimulates aldosterone secretion. By reducing its
levels, these drugs promote vasodilation and decrease fluid retention. This dual action effectively lowers
systemic blood pressure in hypertensive patients. They are also known for their renal protective effects
in diabetic individuals. However, the accumulation of bradykinin during this process often results in a dry
cough.
,4. Which side effect is a common reason for patients to discontinue ACE inhibitor therapy?
A. Dry, non-productive cough
B. Hypokalemia
C. Tachycardia
D. Peripheral edema
Ans: A
Rationale: A dry, non-productive cough is a hallmark side effect of ACE inhibitor use. This occurs due to
the inhibition of bradykinin breakdown in the lungs. While the cough is generally harmless, it can be
persistent and bothersome to patients. Many patients find the symptom intolerable and request a change
in medication. Switching to an Angiotensin Receptor Blocker usually resolves the issue while maintaining
efficacy. Clinicians should educate patients about this potential outcome before starting therapy.
5. Warfarin therapy is monitored primarily using which laboratory value?
A. Activated partial thromboplastin time (aPTT)
B. International Normalized Ratio (INR)
C. Platelet count
D. Serum creatinine
Ans: B
Rationale: The INR is the standard laboratory test used to monitor the effectiveness of Warfarin. It
provides a consistent measurement regardless of the laboratory reagents used. Maintaining a therapeutic
INR range is vital for preventing both thrombosis and hemorrhage. Most clinical indications require an
, INR range between two and three. Changes in diet or other medications can significantly fluctuate these
levels. Frequent monitoring ensures that the patient remains within the safe therapeutic window.
6. Why is Metformin generally contraindicated in patients with significant renal impairment?
A. Risk of hypoglycemia
B. Risk of lactic acidosis
C. Risk of hepatotoxicity
D. Risk of weight gain
Ans: B
Rationale: Metformin is primarily excreted unchanged by the kidneys during the elimination process. If
renal function is impaired, the drug can accumulate to dangerous levels. This accumulation increases the
risk of developing a condition called lactic acidosis. Lactic acidosis is a rare but life-threatening
complication characterized by low pH. Current guidelines suggest avoiding Metformin when the
glomerular filtration rate falls too low. Monitoring renal function periodically is a standard requirement
for all patients on this drug.
7. Which class of antibiotics is associated with an increased risk of tendon rupture?
A. Macrolides
B. Cephalosporins
C. Fluoroquinolones
D. Tetracyclines
Ans: C
Fundamentals V3 Updated and Latest Questions and
Correct Answers with Rationale
1. Which pharmacokinetic process is most affected by the first-pass effect?
A. Metabolism
B. Excretion
C. Absorption
D. Distribution
Ans: A
Rationale: The first-pass effect primarily involves the metabolism of a drug within the liver. When an
oral medication is absorbed from the gastrointestinal tract, it enters the portal circulation. This process
allows the liver to chemically alter the drug before it reaches the systemic bloodstream. Consequently,
the bioavailability of the drug can be significantly reduced depending on the liver’s efficiency. Prescribers
must consider this when transitioning from intravenous to oral dosing routes. Understanding this
mechanism helps in predicting potential therapeutic failures or toxicities.
2. Which enzyme system is primarily responsible for the phase I metabolism of most drugs?
A. Alcohol dehydrogenase
B. Glucuronosyltransferase
C. Monoamine oxidase
D. Cytochrome P450
Ans: D
,Rationale: The Cytochrome P450 enzyme system is the major catalyst for drug biotransformation in
humans. These enzymes are located mainly in the endoplasmic reticulum of hepatocytes. They facilitate
oxidation, reduction, and hydrolysis reactions during phase I metabolism. Variability in these enzymes
can lead to significant differences in drug response among patients. Some drugs may induce or inhibit
these enzymes, leading to complex drug-drug interactions. Proper assessment of a patient’s medication
profile requires knowledge of these metabolic pathways.
3. What is the primary mechanism of action of ACE inhibitors in treating hypertension?
A. Inhibiting the conversion of Angiotensin I to Angiotensin II
B. Blocking calcium entry into smooth muscle
C. Antagonizing beta-1 adrenergic receptors
D. Promoting sodium excretion in the distal tubule
Ans: A
Rationale: ACE inhibitors work by blocking the enzyme responsible for creating Angiotensin II.
Angiotensin II is a potent vasoconstrictor that also stimulates aldosterone secretion. By reducing its
levels, these drugs promote vasodilation and decrease fluid retention. This dual action effectively lowers
systemic blood pressure in hypertensive patients. They are also known for their renal protective effects
in diabetic individuals. However, the accumulation of bradykinin during this process often results in a dry
cough.
,4. Which side effect is a common reason for patients to discontinue ACE inhibitor therapy?
A. Dry, non-productive cough
B. Hypokalemia
C. Tachycardia
D. Peripheral edema
Ans: A
Rationale: A dry, non-productive cough is a hallmark side effect of ACE inhibitor use. This occurs due to
the inhibition of bradykinin breakdown in the lungs. While the cough is generally harmless, it can be
persistent and bothersome to patients. Many patients find the symptom intolerable and request a change
in medication. Switching to an Angiotensin Receptor Blocker usually resolves the issue while maintaining
efficacy. Clinicians should educate patients about this potential outcome before starting therapy.
5. Warfarin therapy is monitored primarily using which laboratory value?
A. Activated partial thromboplastin time (aPTT)
B. International Normalized Ratio (INR)
C. Platelet count
D. Serum creatinine
Ans: B
Rationale: The INR is the standard laboratory test used to monitor the effectiveness of Warfarin. It
provides a consistent measurement regardless of the laboratory reagents used. Maintaining a therapeutic
INR range is vital for preventing both thrombosis and hemorrhage. Most clinical indications require an
, INR range between two and three. Changes in diet or other medications can significantly fluctuate these
levels. Frequent monitoring ensures that the patient remains within the safe therapeutic window.
6. Why is Metformin generally contraindicated in patients with significant renal impairment?
A. Risk of hypoglycemia
B. Risk of lactic acidosis
C. Risk of hepatotoxicity
D. Risk of weight gain
Ans: B
Rationale: Metformin is primarily excreted unchanged by the kidneys during the elimination process. If
renal function is impaired, the drug can accumulate to dangerous levels. This accumulation increases the
risk of developing a condition called lactic acidosis. Lactic acidosis is a rare but life-threatening
complication characterized by low pH. Current guidelines suggest avoiding Metformin when the
glomerular filtration rate falls too low. Monitoring renal function periodically is a standard requirement
for all patients on this drug.
7. Which class of antibiotics is associated with an increased risk of tendon rupture?
A. Macrolides
B. Cephalosporins
C. Fluoroquinolones
D. Tetracyclines
Ans: C
